| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2802332302016 | 233230201 | MIRAPEXIN TAB 0,18MG/TAB BTx30 σε BLISTERS | 3.74 | 3.93 | 5.42 |
| 05/2018 | 2802332302023 | 233230202 | MIRAPEXIN TAB 0,18MG/TAB BTx100 σε BLISTERS | 11.63 | 12.20 | 16.81 |
| 05/2018 | 2802332303013 | 233230301 | MIRAPEXIN TAB 0,7MG/TAB BTx30 σε BLISTERS | 14.53 | 15.24 | 21.00 |
| 05/2018 | 2802332303020 | 233230302 | MIRAPEXIN TAB 0,7MG/TAB BTx100 σε BLISTERS | 46.20 | 48.46 | 66.78 |
| 05/2018 | 2802332307011 | 233230701 | MIRAPEXIN PR.TAB 0,26MG/TAB BTx10 σε BLIST (PA/ALU/PVC) (PA/ALU/PVC) | 2.35 | 2.46 | 3.39 |
| 05/2018 | 2802332308018 | 233230801 | MIRAPEXIN PR.TAB 0,52MG/TAB BTx10 σε BLIST (PA/ALU/PVC) (PA/ALU/PVC) | 5.18 | 5.44 | 7.49 |
| 05/2018 | 2802332309022 | 233230902 | MIRAPEXIN PR.TAB 1,05MG/TAB BTx30 σε BLIST (PA/ALU/PVC) (PA/ALU/PVC) | 20.21 | 21.20 | 29.21 |
| 05/2018 | 2802332310028 | 233231002 | MIRAPEXIN PR.TAB 2,1MG/TAB BTx30 σε BLIST (PA/ALU/PVC) (PA/ALU/PVC) | 36.25 | 38.03 | 52.41 |
| 05/2018 | 2802332311025 | 233231102 | MIRAPEXIN PR.TAB 3,15MG/TAB BTx30 σε BLIST (PA/ALU/PVC) (PA/ALU/PVC) | 67.37 | 70.67 | 89.89 |
For the treatment of signs and symptoms of idiopathic Parkinson's disease
The precise mechanism of action of Pramipexole as a treatment for Parkinson's disease is unknown, although it is believed to be related to its ability to stimulate dopamine receptors in the striatum.
Rapid. Absolute bioavailability is greater than 90%, indicating that pramipexole is well absorbed and undergoes little presystemic metabolism. Food does not affect the extent of absorption.
8 hours
Urinary excretion is the major route of pramipexole elimination, with 90% of a pramipexole dose recovered in urine, almost all as unchanged drug. Nonrenal routes may contribute to a small extent to pramipexole elimination, although no metabolites have been identified in plasma or urine.
* 500 L
* renal cl=400 mL/min